Viral Hepatitis
Copyright ©The Author(s) 2003.
World J Gastroenterol. Sep 15, 2003; 9(9): 2012-2016
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.2012
Table 1 Clinical data for patients with HBV and/or HCV infection
Group BCGroup BGroup CStatistical value
Number of patients401631
Sex (male/female)21/196/1015/16χ2 = 1.030, P > 0.05
Age (y)a39 ± 5 (29-50)40 ± 6 (31-53)39 ± 3 (32-44)F = 0.48, P > 0.05
Time of infection (y)a16 ± 5 (14-21)16 ± 5 (14-21)17 ± 4 (14-21)F = 2.27, P > 0.05
Serological markers (1994)
HBsAg +34 (85.0%)16 (100%)0
HBeAg +11 (27.5%)7 (43.8%)0
HBVDNA +37 (92.5%)14 (87.5%)0
HCVRNA +11 (27.5%)0 (0%)19 (61.3%)
Anti-HCV39 (97.5%)0 (0%)31 (100.0%)